Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • See Evidence submitted by expert panel for details.

Variant: NM_001126112.2(TP53):c.380C>A (p.Ser127Tyr)

CA397843908

656751 (ClinVar)

Gene: TP53
Condition: Li-Fraumeni syndrome 1
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: 69da5ddc-e144-48e0-aa76-30754f54757b
Approved on: 2021-04-20
Published on: 2021-06-16

HGVS expressions

NM_001126112.2:c.380C>A
NM_001126112.2(TP53):c.380C>A (p.Ser127Tyr)
NC_000017.11:g.7675232G>T
CM000679.2:g.7675232G>T
NC_000017.10:g.7578550G>T
CM000679.1:g.7578550G>T
NC_000017.9:g.7519275G>T
NG_017013.2:g.17319C>A
ENST00000503591.2:c.380C>A
ENST00000508793.6:c.380C>A
ENST00000509690.6:c.-17C>A
ENST00000514944.6:c.101C>A
ENST00000604348.6:c.376-17C>A
ENST00000269305.9:c.380C>A
ENST00000269305.8:c.380C>A
ENST00000359597.8:c.380C>A
ENST00000413465.6:c.380C>A
ENST00000420246.6:c.380C>A
ENST00000445888.6:c.380C>A
ENST00000455263.6:c.380C>A
ENST00000503591.1:c.380C>A
ENST00000504290.5:c.-17C>A
ENST00000504937.5:c.-17C>A
ENST00000505014.5:n.636C>A
ENST00000508793.5:c.380C>A
ENST00000509690.5:c.-17C>A
ENST00000510385.5:c.-17C>A
ENST00000514944.5:c.101C>A
ENST00000604348.5:c.376-17C>A
ENST00000610292.4:c.263C>A
ENST00000610538.4:c.263C>A
ENST00000610623.4:c.-98C>A
ENST00000615910.4:c.347C>A
ENST00000617185.4:c.380C>A
ENST00000618944.4:c.-98C>A
ENST00000619186.4:c.-98C>A
ENST00000619485.4:c.263C>A
ENST00000620739.4:c.263C>A
ENST00000622645.4:c.263C>A
ENST00000635293.1:c.263C>A
NM_000546.5:c.380C>A
NM_001126113.2:c.380C>A
NM_001126114.2:c.380C>A
NM_001126115.1:c.-17C>A
NM_001126116.1:c.-17C>A
NM_001126117.1:c.-17C>A
NM_001126118.1:c.263C>A
NM_001276695.1:c.263C>A
NM_001276696.1:c.263C>A
NM_001276697.1:c.-98C>A
NM_001276698.1:c.-98C>A
NM_001276699.1:c.-98C>A
NM_001276760.1:c.263C>A
NM_001276761.1:c.263C>A
NM_001276695.2:c.263C>A
NM_001276696.2:c.263C>A
NM_001276697.2:c.-98C>A
NM_001276698.2:c.-98C>A
NM_001276699.2:c.-98C>A
NM_001276760.2:c.263C>A
NM_001276761.2:c.263C>A
NM_000546.6:c.380C>A
NM_001126112.3:c.380C>A
NM_001126113.3:c.380C>A
NM_001126114.3:c.380C>A
NM_001126115.2:c.-17C>A
NM_001126116.2:c.-17C>A
NM_001126117.2:c.-17C>A
NM_001126118.2:c.263C>A
NM_001276695.3:c.263C>A
NM_001276696.3:c.263C>A
NM_001276697.3:c.-98C>A
NM_001276698.3:c.-98C>A
NM_001276699.3:c.-98C>A
NM_001276760.3:c.263C>A
NM_001276761.3:c.263C>A
More

Pathogenic

Met criteria codes 6
PP1 PS3 PM1 PS4_Supporting PP3_Moderate PM2_Supporting
Not Met criteria codes 4
PS1 BP4 BS3 BS2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
TP53 VCEP
This variant is absent in the gnomAD cohort (PM2_Supporting; http://gnomad.broadinstitute.org). This variant has a BayesDel score > 0.16 and Align GVGD (Zebrafish) is Class 65 (PP3_Moderate). This variant has >10 observations as a somatic hotspot variant in tumors (PM1; cancerhotspots.org v(2)). Transactivation assays show a low functioning allele according to Kato, et al. and there is an in vitro proliferation assay demonstrating loss of function (PS3; PMID: 12826609, PMID: 25584008). This variant has been reported in 2 probands meeting Chompret criteria (PS4; internal laboratory contributors). This variant was found to co-segregate with disease in multiple affected family members, with 3 meioses observed (PP1; internal laboratory contributor). In summary, TP53 c.380C>A (p.Ser127Tyr) meets criteria to be classified as Pathogenic for Li-Fraumeni syndrome. ACMG/AMP criteria applied, as specified by the TP53 Variant Curation Expert Panel: PM2_Supporting, PP3_Moderate, PM1, PS3, PS4_Supporting, PP1.
Met criteria codes
PP1
Variant observed in 3 meioses in family segregating breast and brain cancer in Ambry internal data
PS3
Kato non-functional, Kotler LOF, Giacomelli DNE but not LOF.
PM1
Yes, 10/48 samples on cancerhotspots.com
PS4_Supporting
1 Chompret case from NIH cohort = 0.5 pts. 1 Chompret case from Ambry labs = 0.5 points. 1 point total.
PP3_Moderate
aGVGD = C65; BayesDel = 0.6001
PM2_Supporting
Absent from gnomAD (non-cancer)
Not Met criteria codes
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
Not present in FLOSSIES. Internal lab data not received.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.